Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

References

• World Health Organization Safety of Medicines - A Guide to Detecting and Reporting Adverse Drug Reactions - Why Health Professionals Need to Take Action 2002. [22 Nov 2018]. http://apps.who.int/iris/bitstream/handle/10665/67378/WHO_EDM_QSM_2002.2. pdf;jsessionid=BA5B4BE506C2FB1820A7326529B9D9FB?sequence=1.
   Google Scholar
• Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–1205.
   PubMed Web of Science ®Google Scholar
• White TJ, Arakelian A, Rho JP. Counting the costs of drug-related adverse events. Pharmacoeconomics. 1999;15:445–458.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Monguió R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. PharmacoEconomics. 2003;21:623–650.
   PubMed Web of Science ®Google Scholar
• Freitas GRM, Tramontina MY, Balbinotto G, et al. Economic impact of emergency visits due to drug-related morbidity on a Brazilian hospital. Value Health Reg Issues. 2017;14:1–8.
   PubMedGoogle Scholar
• Sousa-Pinto B, Marques B, Lopes F, et al. Frequency and impact of adverse events in inpatients: a nationwide analysis of episodes between 2000 and 2015. J Med Syst. 2018;42:48.
   PubMed Web of Science ®Google Scholar
• Gyllensten H, Hakkarainen KM, Hägg S, et al. Economic impact of adverse drug events–a retrospective population-based cohort study of 4970 adults. PLoS One. 2014;9:e92061.
   PubMed Web of Science ®Google Scholar
• Schurig AM, Böhme M, Just KS, et al. Adverse drug reactions (ADR) and emergencies. Dtsch Arztebl Int. 2018;115:251–258.
   PubMed Web of Science ®Google Scholar
• Scripcaru G, Mateus C, Nunes C. Adverse drug events - analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database. PLoS One. 2017;12:e0178626.
   PubMed Web of Science ®Google Scholar
• Rydberg DM, Holm L, Engqvist I, et al. Adverse drug reactions in a tertiary care emergency medicine ward - prevalence, preventability and reporting. PLoS One. 2016;11:e0162948.
   PubMed Web of Science ®Google Scholar
• Walter SR, Day RO, Gallego B, et al. The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia. Br J Clin Pharmacol. 2017;83:416–426.
   PubMed Web of Science ®Google Scholar
• Angamo MT, Chalmers L, Curtain CM, et al. Adverse-drug-reaction-related hospitalizations in developed and developing countries: a review of prevalence and contributing Factors. Drug Saf. 2016;39:847–857.
   PubMed Web of Science ®Google Scholar
• de Vries EN, Ramrattan MA, Smorenburg SM, et al. The incidence and nature of in-hospital adverse events: a systematic review . Qual Saf Health Care. 2008;17:216–223.
   PubMed Web of Science ®Google Scholar
• Hakkarainen KM, Hedna K, Petzold M, et al. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions-a meta-analysis. PLoS One. 2012;7:e33236.
   PubMed Web of Science ®Google Scholar
• Türkiye İlaç ve Tıbbi Cihaz Kurumu, İlaçların Güvenliliği Hakkında Yönetmelik Resmi Gazete [Turkey Pharmaceuticals and Medical Devices Agency, Legislation on Drug Safety Official Gazette] No: 28973 2014 [April 2018]. Available from: http://www.resmigazete.gov.tr/eskiler/2014/04/20140415-6.htm Turkish.
   Google Scholar
• Türkiye İlaç ve Tıbbi Cihaz Kurumu Türkiye Farmakovijilans Merkezi internet sayfası [Turkish Medicines and Medical Devices Agency Turkish Pharmacovigilance Center. web page] [April 2018]. Available from: http://www.titck.gov.tr/Ilac/Farmakovijilans Turkish.
   Google Scholar
• Aagaard L, Strandell J, Melskens L, et al. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Drug Saf. 2012;35:1171–1182.
   PubMed Web of Science ®Google Scholar
• Ozcan G, Aykac E, Kasap Y, et al. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs Real World Outcomes. 2016;3:33–43.
   PubMedGoogle Scholar
• Avong YK, Jatau B, Gurumnaan R, et al. Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: a prospective cohort study. PLoS One. 2018;13:e0200810.
   PubMed Web of Science ®Google Scholar
• Hohl CM, Small SS, Peddie D, et al. Why clinicians don't report adverse drug events: qualitative study. JMIR Public Health Surveill. 2018;4:e21.
   PubMedGoogle Scholar
• Hazell L, Shakir SA. Under-reporting of adverse drug reactions : a systematic review. Drug Saf. 2006;29:385–396.
   PubMed Web of Science ®Google Scholar
• Rivkees SA. Primum non nocere (first, not to harm) and secundus, opinion vulnero (second, report the harm). Int J Pediatr Endocrinol. 2009;2009:303509.
   PubMedGoogle Scholar
• The World Bank Group. Country classifications 2017 [online]. [22 Nov 2018]. 2017. http://data.worldbank.org/about/country-classifications
   Google Scholar
• Aydınkarahaliloğlu ND, Aykaç E, Atalan Ö, et al. Spontaneous reporting of adverse drug reactions by consumers in comparison with healthcare professionals in Turkey from 2014 to 2016. Pharm Med. 2018;32:353.
   Web of Science ®Google Scholar
• Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9:14.
   PubMedGoogle Scholar
• Desai CK, Iyer G, Panchal J, et al. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011;2:129–136.
   PubMedGoogle Scholar
• Santosh KC, Tragulpiankit P, Gorsanan S, et al. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal. BMC Pharmacol Toxicol. 2013;14:16.
   PubMed Web of Science ®Google Scholar
• Hajj A, Hallit S, Ramia E, et al. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon. Curr Med Res Opin. 2018;34:149–156.
   PubMed Web of Science ®Google Scholar
• Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008;30:556–562.
   PubMedGoogle Scholar
• Alan S, Ozturk M, Gokyildiz S, et al. An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey. Indian J Pharmacol. 2013;45:616–618.
   PubMed Web of Science ®Google Scholar
• Vural F, Ciftci S, Vural B. The knowledge, attitude and behaviours of nurses about pharmacovigilance, adverse drug reaction and adverse event reporting in a state hospital. North Clin Istanb. 2015;1:147–152.
   PubMedGoogle Scholar
• Ergün Y, Ergün TB, Toker E, et al. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. Int Health. 2018;. [Epub ahead of print]. DOI: 10.1093/inthealth/ihy073
   PubMed Web of Science ®Google Scholar
• Thorne RJ, Bruggink RJ, Kelly SJ, et al. Awareness and compliance with pharmacovigilance requirements amongst UK oncology healthcare professionals. Ecancermedicalscience. 2018;12:809.
   PubMed Web of Science ®Google Scholar
• Ribeiro-Vaz I, Santos CC, Cruz-Correia R. Promoting adverse drug reaction reporting: comparison of different approaches. Rev Saude Publica. 2016;50:14.
   PubMed Web of Science ®Google Scholar
• Ganesan S, Sandhiya S, Reddy KC, et al. The impact of the educational intervention on knowledge, attitude, and practice of pharmacovigilance toward adverse drug reactions reporting among health-care professionals in a tertiary care hospital in South India. J Nat Sci Biol Med. 2017;8:203–209.
   PubMedGoogle Scholar
• Leporini C, Marrazzo G, Mumoli L, et al. Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European legislation. Expert Opin Drug Saf. 2017;16:515–522.
   PubMed Web of Science ®Google Scholar
• Schutte T, van Eekeren R, Richir M, et al. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study. Naunyn-Schmiedeberg's Arch Pharmacol. 2018;391:17–26.
   Google Scholar
• Varallo FR, Planeta CS, Mastroianni PC. Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics (Sao Paulo). 2017;72:51–57.
   PubMed Web of Science ®Google Scholar
• Bigi C, Bocci G. The key role of clinical and community health nurses in pharmacovigilance. Eur J Clin Pharmacol. 2017;73:1379–1387.
   PubMed Web of Science ®Google Scholar
• Sinclair P, Kable A, Levett-Jones T. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol. JBI Database System Rev Implement Rep. 2015;13:52–64.
   PubMedGoogle Scholar
• Cheema E, Haseeb A, Khan TM, et al. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom. Pharm Pract (Granada). 2017;15:931.
   PubMed Web of Science ®Google Scholar
• Kraus CN, Baldwin AT, McAllister RG. Jr. Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical education. Curr Drug Saf. 2013;8:11–16.
   PubMedGoogle Scholar
• Franklin BD, O'Grady K, Parr J, et al. Using the internet to deliver education on drug safety. Qual Saf Health Care. 2006;15:329–333.
   PubMedGoogle Scholar